EP Patent

EP0281841B1 — Verfahren zur Herstellung von 5-Amino-4,6-dihalogenpyridinen

Assigned to Bayer AG · Expires 1990-11-14 · 36y expired

What this patent protects

Patent listed against Augtyro.

Drugs covered by this patent

Augtyro (REPOTRECTINIB) · Bristol

Patent Metadata

Patent number: EP0281841B1
Jurisdiction: EP
Classification: —
Expires: 1990-11-14
Drug substance claim: No
Drug product claim: No
Assignee: Bayer AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.